← Open Payments lookup

KAITLYN GEISS: Open Payments

NPI 1881174324 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$994 in 49 payments from 12 companies in 2025. Trend: 2023 $1,281 · 2024 $1,307 · 2025 $994

Food & beverage: $994
CompanyPaymentsAmount
Janssen Biotech, Inc.10$201
ABBVIE INC.11$173
GENZYME CORPORATION3$118
Takeda Pharmaceuticals U.S.A., Inc.5$98
Gilead Sciences, Inc.5$84
Salix Pharmaceuticals, a division of Bausch Health US, LLC4$84
Lilly USA, LLC3$73
Ardelyx, Inc.3$62
Regeneron Healthcare Solutions, Inc.2$53
Phathom Pharmaceuticals, Inc.1$17

Products named: TREMFYA, DUPIXENT, RINVOQ, ENTYVIO, XIFAXAN, OMVOH, IBSRELA, MAVYRET.

Industry payments across IN — which companies pay providers there.